Burning Rock Biotech Limited (BNR)

EBITDA Margin

-11.67%

Quarterly · Period ending:

BNR logo

BNR EBITDA Margin

Latest reported-11.67%
BNR Quarterly EBITDA Margin (-65.18% → -11.67%)
High-resolution chart · PNG

BNR ebitda margin history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Burning Rock Biotech Limited EBITDA Margin — Quarterly
Period endingEBITDA Margin
-11.6729%
-15.9575%
5.7523%
-12.5599%
-4.7747%
-9.9758%
-11.189%
-23.0296%
-79.5732%
-90.8033%
-34.8394%
-129.5937%
-83.3071%
-123.2805%
-144.2628%
-144.2936%
-193.7546%
-184.644%
-138.7458%
-127.6087%
-141.2818%
-153.5773%
-111.0446%
-94.3997%
-61.1278%
-64.868%
-105.9107%
-22.3214%
-20.3896%
-4.4158%
-65.1806%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.